Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Aclaris Therapeutics has raised $50.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2026.
Aclaris Therapeutics's investors include RA Capital Management, Invus, TCG Crossover, Cormorant Asset Management, Vivo Capital.
Aclaris Therapeutics is headquartered in Wayne, United States.
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Aclaris Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aclaris Therapeutics — Funding & Investors." VCBacked, October 27, 2026, https://www.vcbacked.co/company/aclaris-therapeutics. Accessed November 5, 2026.
VCBacked. (2026). Aclaris Therapeutics — Funding & Investors. Retrieved November 5, 2026, from https://www.vcbacked.co/company/aclaris-therapeutics
{{cite web |title=Aclaris Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aclaris-therapeutics |website=VCBacked |access-date=November 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Aclaris Therapeutics? Request a listing update